City

Chicago (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Phase

phase 2 (2)

Sponsor

Alliance for Clinical Trials in Oncology (1)

University of Chicago (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

computed tomography (1)

ipilimumab (1)

laboratory biomarker analysis (1)

magnetic resonance imaging (1)

nivolumab (1)

pembrolizumab (1)

pharmacogenomic study (1)

positron emission tomography (1)

surgical procedure (1)

Study Documents

Intervention Type

biological (2)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

pleural biphasic mesothelioma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

Not yet recruiting

Pleural Biphasic Mesothelioma
Pleural Sarcomatoid Mesothelioma

Nivolumab
+5 more

(no location specified)

Dec 9, 2022

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting

Biphasic Mesothelioma
+9 more

Pembrolizumab
+2 more

Chicago, Illinois

University of Chicago

Apr 18, 2022